VEGFA and urinary bladder carcinoma: Furthermore, CID 5951923, a specific KLF5 transcriptional inhibitor identified by cell-based ultrahigh-throughput screening [13], abolished KLF5 and VEGFA expression in 5637 and WH bladder cancer cells, suggesting potential application of KLF5 inhibitor in bladder cancer treatment.